Smith BioMed (NZ) Ltd.,is an importer / distributer of a range of medical diagnostics, specialising in rapid on-site drug testing systems. It has supply contracts with New Zealand government agencies. Other markets include hospitals; re-habilitation centres; high safety risk iindustries such as airline,forestry;meat producing and construction. It is privately owned and has been trading successfully for some 8 years now. Due to a cancelled government contract it has currently excess stock of pregnancy which it will sell overseas. This stock was imported from the USA, has FDA approval and utilises the latest design technology. The company is prepared to sell this stock at significantly below cost by offering US$0.15 CIF per test.If you require any additional information, please let me know.Regards,John M.SmithC.E.O.
